Table 1.
Eligibility
criteria |
Random
allocation |
Concealed
allocation |
Baseline
comparability |
Blind
subjects |
Blind
therapists |
Blind
assessors |
Adequate
follow-up |
Intention-
to-treat analysis |
Between-group
comparisons |
Point estimates and variability | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Adams et al. (19) | √ | √ | 0 | √ | 0 | 0 | √ | √ | √ | √ | √ | 8/11 |
Frederix (20) | √ | √ | 0 | √ | 0 | 0 | √ | √ | √ | √ | √ | 8/11 |
Haggerty et al. (21) | √ | √ | 0 | √ | 0 | 0 | √ | 0 | 0 | √ | 0 | 5/11 |
Haller et al. (22) | √ | √ | √ | √ | 0 | 0 | 0 | 0 | √ | √ | √ | 7/11 |
Holmen et al. (23) | √ | √ | √ | √ | 0 | 0 | √ | 0 | √ | √ | 0 | 7/11 |
Hutchesson et al. (24) | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | 11/11 |
Kempf et al. (25) | √ | √ | √ | √ | 0 | 0 | 0 | √ | 0 | √ | 0 | 6/11 |
Lari et al. (26) | √ | √ | 0 | √ | 0 | 0 | 0 | √ | √ | √ | √ | 7/11 |
Li et al. (27) | √ | √ | 0 | √ | 0 | 0 | 0 | √ | √ | √ | √ | 7/11 |
Maddison et al. (28) | √ | √ | 0 | √ | 0 | 0 | 0 | √ | √ | √ | √ | 7/11 |
Martin et al. (29) | √ | √ | √ | √ | 0 | 0 | 0 | √ | √ | √ | √ | 8/11 |
Partridge et al. (30) | √ | √ | √ | √ | 0 | 0 | 0 | √ | 0 | √ | 0 | 6/11 |
Pfaeffli Dale et al. (31) | √ | √ | 0 | 0 | 0 | 0 | 0 | 0 | √ | √ | √ | 5/11 |
Sharma et al. (32) | √ | √ | 0 | √ | 0 | 0 | 0 | √ | 0 | √ | 0 | 5/11 |
Short et al. (33) | √ | √ | √ | √ | 0 | 0 | 0 | 0 | √ | √ | √ | 7/11 |
Simons et al. (34) | √ | √ | 0 | √ | 0 | 0 | 0 | √ | 0 | √ | 0 | 5/11 |
Spring et al. (35) | √ | √ | √ | √ | 0 | 0 | √ | 0 | 0 | √ | √ | 7/11 |
Wayne et al. (36) | √ | √ | √ | √ | 0 | 0 | 0 | 0 | √ | √ | √ | 7/11 |